Co-Authors
This is a "connection" page, showing publications co-authored by Fabrizio D'Ascenzo and Andrea Rognoni.
Connection Strength
2.048
-
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry. Int J Cardiol. 2021 06 01; 332:227-234.
Score: 0.234
-
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy. Int J Cardiol. 2021 06 01; 332:235-237.
Score: 0.234
-
Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak. Am J Cardiovasc Dis. 2020; 10(4):506-513.
Score: 0.227
-
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life). Int J Cardiol. 2019 09 01; 290:64-69.
Score: 0.204
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020 05; 27(7):696-705.
Score: 0.203
-
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):536-542.
Score: 0.197
-
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry. Int J Cardiol. 2018 Dec 15; 273:29-33.
Score: 0.196
-
Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry. Eur Heart J Cardiovasc Imaging. 2018 05 01; 19(5):524-531.
Score: 0.191
-
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak. ESC Heart Fail. 2020 Oct 23.
Score: 0.057
-
Outcomes of acute coronary syndromes in coronavirus disease 2019. Clin Res Cardiol. 2020 Dec; 109(12):1601-1604.
Score: 0.056
-
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med. 2020 07 02; 383(1):88-89.
Score: 0.055
-
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):215-223.
Score: 0.049
-
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. Rev Esp Cardiol (Engl Ed). 2019 Apr; 72(4):298-304.
Score: 0.048
-
Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study. Int J Cardiol. 2018 Nov 01; 270:107-112.
Score: 0.048
-
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. Thromb Res. 2018 07; 167:142-148.
Score: 0.048